TRANSLATE BIO INC's ticker is TBIO and the CUSIP is 89374L104. A total of 151 filers reported holding TRANSLATE BIO INC in Q4 2020. The put-call ratio across all filers is 7.16 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $1,327,000 | -17.7% | 48,208 | -50.7% | 0.00% | 0.0% |
| Q1 2021 | $1,613,000 | -62.5% | 97,795 | -58.1% | 0.00% | -50.0% |
| Q4 2020 | $4,299,000 | +332.5% | 233,200 | +219.3% | 0.00% | +100.0% |
| Q3 2020 | $994,000 | +17.4% | 73,039 | +54.6% | 0.00% | 0.0% |
| Q2 2020 | $847,000 | +636.5% | 47,248 | +310.8% | 0.00% | – |
| Q1 2020 | $115,000 | -64.5% | 11,502 | -71.1% | 0.00% | – |
| Q4 2019 | $324,000 | +77.0% | 39,829 | +115.1% | 0.00% | – |
| Q3 2019 | $183,000 | -23.4% | 18,513 | -2.2% | 0.00% | – |
| Q2 2019 | $239,000 | +165.6% | 18,938 | +114.0% | 0.00% | – |
| Q1 2019 | $90,000 | +80.0% | 8,848 | +31.9% | 0.00% | – |
| Q4 2018 | $50,000 | +35.1% | 6,710 | +82.8% | 0.00% | – |
| Q3 2018 | $37,000 | – | 3,671 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Atlas Venture Advisors, Inc. | 2,656,517 | $48,960,000 | 10.98% |
| Copernicus Capital Management, LLC | 12,091 | $223,000 | 3.48% |
| FRAZIER MANAGEMENT LLC | 2,182,789 | $40,229,000 | 3.10% |
| Baupost Group | 18,044,239 | $326,236,000 | 3.01% |
| DAFNA Capital Management LLC | 225,393 | $4,154,000 | 1.24% |
| RTW INVESTMENTS, LP | 2,978,427 | $54,892,000 | 0.92% |
| MARATHON CAPITAL MANAGEMENT | 143,275 | $2,640,000 | 0.78% |
| Bain Capital Public Equity Management II, LLC | 627,387 | $11,563,000 | 0.59% |
| Artal Group S.A. | 1,200,000 | $22,116,000 | 0.48% |
| Birchview Capital, LP | 30,000 | $553,000 | 0.32% |